Zhou Liwei has served as the Standing Committee of Shandong Provincial Party Committee and Minister of Organization Department. According to the website of Shandong Provincial Commission for Discipline Inspection and Supervision, on December 11th, the 12th Anti-corruption Coordination Group of the Provincial Party Committee held its fourth meeting to convey the spirit of studying the anti-corruption work of the CPC Central Committee, comprehensively summarize the anti-corruption work in Shandong Province, and study and deploy key tasks. Xia Hongmin, member of the Standing Committee of the Provincial Party Committee, secretary of the Provincial Discipline Inspection Commission, director of the Provincial Supervision Commission and leader of the provincial anti-corruption coordination group, presided over the meeting and delivered a speech. Zhou Liwei, member of the Standing Committee of the Provincial Party Committee, director of the Organization Department and deputy head of the provincial anti-corruption coordination group, Li Wei, deputy governor and director of the provincial public security department, Huo Min, president of the provincial court, Gu Xuefei, chief procurator of the provincial procuratorate, Lei Yun, deputy secretary of the provincial discipline inspection commission and deputy director of the provincial supervision commission, and other members of the provincial anti-corruption coordination group attended the meeting. This shows that Zhou Liwei has served as the Standing Committee of Shandong Provincial Party Committee and Minister of Organization Department.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.Argentine President Millay: It will take four years to close the central bank. According to the video released by the media Infobae on Tuesday, Argentine President Millay said that it will take four years to close the country's central bank. Millay predicts that the economy will grow and inflation will fall next year. When asked about the possibility of closing the Argentine central bank in 2025, he said, "We don't have time. I have always said that it will take four years, and I have only been in power for one year. "
*ST Hanma: The reorganization plan of the company and its five subsidiaries was approved by the court. On December 11, 2024, the company and its five subsidiaries, Anhui Valin Automobile Co., Ltd., Anhui Xingma Special Purpose Vehicle Co., Ltd., Anhui Fuma Automobile Parts Group Co., Ltd., Anhui Fuma Electronic Technology Co., Ltd. and Wuhu Fuma Automobile Parts Co., Ltd., received the court ruling, approved their reorganization plans and terminated the reorganization procedures, and then entered the implementation stage.After the strike ended, the delivery of Boeing aircraft dropped to 13 in November. On Tuesday, Boeing reported that it delivered 13 commercial jets in November, less than a quarter of the 56 jets delivered to customers 12 months ago. The number of deliveries in October decreased from 14 in October, when most of the company's aircraft production was still in a state of suspension, and 33,000 factory workers went on strike for seven weeks, which ended on November 5. Boeing shares closed up 4.5% on Tuesday. The aircraft manufacturer said that after weeks of methodical preparations, the company restarted the production of the 737 MAX and loaded the new fuselage into the Renton factory in Seattle.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.
The General Administration of Market Supervision held an anti-monopoly compliance lecture hall for the automobile industry. On December 11th, the General Administration of Market Supervision held the ninth anti-monopoly compliance lecture hall in Beijing to give lectures on anti-monopoly compliance for the automobile industry. The General Administration of Market Supervision requires the business entities of the automobile industry to compact the responsibility of the anti-monopoly compliance subject, actively regulate business practices, establish and improve the anti-monopoly compliance system, and effectively prevent and stop the occurrence of monopoly behaviors. The General Administration of Market Supervision will continue to pay attention to the competition in the automobile industry, further promote the special anti-monopoly law enforcement actions in the field of people's livelihood, promote the formation of a fairer and more dynamic market environment, and continuously enhance the people's sense of acquisition, happiness and security. (City speaks Newspeak)Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Trump appointed TOM BARRACK as the US ambassador to Turkey.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13